Core Viewpoint - Rosen Law Firm is reminding investors who purchased ModivCare Inc. securities between November 3, 2022, and September 15, 2024, of the March 31, 2025, deadline to become lead plaintiffs in a class action lawsuit [1][2]. Group 1: Class Action Details - A class action lawsuit has been filed against ModivCare, and investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][2]. - Investors wishing to serve as lead plaintiffs must file a motion with the court by March 31, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that ModivCare's defendants made materially false and misleading statements and failed to disclose adverse facts about the company's business and operations [4]. - Specific issues cited include the deterioration of free cash flow in ModivCare's non-emergency medical transportation segment, which negatively impacted adjusted EBITDA and liquidity [4].

Core Viewpoint - A class action securities lawsuit has been filed against ModivCare Inc. for alleged securities fraud affecting investors between November 3, 2022, and September 15, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that ModivCare made false statements and concealed information regarding contracts in its Non-Emergency Medical Transportation (NEMT) segment, which led to a deterioration in free cash flow [2]. - Allegations include that contract renegotiations and pricing accommodations negatively impacted the Company's adjusted EBITDA, and that the Company faced liquidity issues [2]. - The defendants' positive statements about ModivCare's business operations and prospects were deemed materially misleading and lacked a reasonable basis [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until March 31, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that the ModivCare class action lawsuit – captioned Kalera v. ModivCare, Inc., No. 25-cv-00306, and pending in the District of Colorado – charges ModivCare, Inc. (NASDAQ: MODV) as well as certain of ModivCare’s executives with violations of the Securities Exchange Act of 1934. If you suffered substantial losses and wish to serve as lead plaintiff of the ModivCare class action lawsuit, please provide your information her ...

Core Viewpoint - A class action securities lawsuit has been filed against ModivCare Inc. for alleged securities fraud affecting investors between November 3, 2022, and September 15, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that ModivCare's NEMT segment contracts led to a deterioration in free cash flow, negatively impacting adjusted EBITDA due to contract renegotiations and pricing accommodations [2]. - The complaint alleges that the company faced liquidity issues and that the defendants made materially misleading positive statements about the company's business and prospects [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until March 31, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - A class action lawsuit has been filed against ModivCare Inc. for alleged violations of federal securities laws, specifically regarding misleading statements about the company's financial performance and liquidity issues [1]. Group 1: Lawsuit Details - The lawsuit pertains to shareholders who purchased ModivCare's securities between November 3, 2022, and September 15, 2024 [1]. - Allegations include that ModivCare made misleading statements about the impact of pricing accommodations and contract renegotiations on its adjusted EBITDA [1]. - The company is also accused of failing to maintain sufficient liquidity during the class period [1]. Group 2: Investor Participation - Shareholders who suffered losses during the specified class period are encouraged to contact the DJS Law Group to participate in the lawsuit [2]. Group 3: DJS Law Group Profile - DJS Law Group specializes in enhancing investor returns through securities class actions, corporate governance litigation, and M&A appraisals [3]. - The firm represents some of the largest hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [3].

Core Viewpoint - ModivCare Inc. is facing allegations of making false statements and concealing information that negatively impacted its financial performance, particularly in its Non-Emergency Medical Transportation (NEMT) segment [1]. Group 1: Allegations and Financial Impact - The complaint alleges that certain contracts in ModivCare's NEMT segment led to a deterioration in the company's free cash flow [1]. - As a result of these issues, the company experienced negative impacts on its adjusted EBITDA due to contract renegotiations and pricing accommodations [1]. - The company reportedly faced insufficient liquidity, and the defendants' positive statements regarding the company's business and prospects were misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - The class period for the allegations spans from November 3, 2022, to September 15, 2024 [1]. - Shareholders who purchased shares during this period are encouraged to register for the class action, with a deadline set for March 31, 2025 [2]. - Participants will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle, and there is no cost or obligation to participate [2]. Group 3: Law Firm's Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against ModivCare, Inc. due to alleged violations of federal securities laws, encouraging affected investors to come forward [2][4]. Group 1: Legal Investigation and Claims - The law firm is urging investors who suffered losses exceeding $50,000 in ModivCare between November 3, 2022, and May 3, 2023, to discuss their legal options [1]. - A federal securities class action has been filed against ModivCare, with a deadline of March 31, 2025, for investors to seek the role of lead plaintiff [2][6]. - The complaint alleges that ModivCare and its executives made false or misleading statements regarding the company's financial health, including issues with contract renegotiations and liquidity [4]. Group 2: Financial Impact and Stock Performance - Following the revelation of ModivCare's financial issues, the company's stock price experienced a significant decline, dropping nearly 10% from $14.12 to $12.72 per share on September 16, 2024, after a negative financial update [5]. - The company revised its 2024 Adjusted EBITDA guidance from a range of $185-$195 million to $170-$180 million, primarily due to pricing accommodations in the NEMT segment [5]. Group 3: Firm Background and Contact Information - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its founding in 1995 and has offices in multiple states [3]. - The firm encourages anyone with information regarding ModivCare's conduct, including whistleblowers and former employees, to reach out [7].

NEW YORK, March 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ModivCare Inc. (NASDAQ: MODV).Shareholders who purchased shares of MODV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/modivcare-inc-loss-submission-form/?id=135475&from=4CLASS PERIOD: November 3, 2022 to Sep ...

NEW YORK, March 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ModivCare Inc. ("ModivCare" or the "Company") (NASDAQ: MODV) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of ModivCare investors who were adversely affected by alleged securities fraud between November 3, 2022 and September 15, 2024. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/modivcare-inc-lawsuit-subm ...

SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired ModivCare, Inc. (NASDAQ: MODV) securities between November 3, 2022 and September 15, 2024. ModivCare provides a suite of integrated supportive care solutions for public and private payors and their members. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: R ...